IP Library Granted Patent US 10,584,343
Granted Patent B2
US 10,584,343 · App. 15/744,246 · Granted Mar 10, 2020

Methods of enhancing translation ability of RNA molecules, treatments, and kits

Inventors: Samie R. Jaffrey (New York, NY); Kate D. Meyer (Durham, NC)
Assignee: Cornell University
C12N15/67C12P19/34C12P21/02C12N2310/333C12N2740/16043
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 10,584,343
App. No.
15/744,246
Granted
Mar 10, 2020
Kind
B2
Abstract

The present invention relates to methods and a kit for enhancing the translation ability of an RNA molecule. The methods involve the use of an RNA molecule comprising a methylated adenosine residue in a 5′ untranslated region (UTR). Also disclosed are methods for eIF4E-independent translation of an RNA molecule and treatment methods.

Claims (10)

1. A method of enhancing the translation ability of an RNA molecule, said method comprising:

providing a cell-free composition comprising an RNA molecule to be translated, wherein the RNA molecule lacks a methylated adenosine residue in a 5′ untranslated region (UTR) and

introducing a methylated adenosine residue in a 5′ untranslated region (UTR) of the RNA molecule, wherein said introducing enhances translation ability of the RNA molecule relative to the RNA molecule lacking a methylated adenosine residue in a 5′ untranslated region (UTR).

2. The method according to claim 1 , wherein the RNA molecule is a synthetic RNA molecule.

3. The method according to claim 1 , wherein the RNA molecule is a naturally-occurring RNA molecule.

4. The method according to claim 1 , wherein the methylated adenosine residue introduced into the 5′ untranslated region (UTR) is m 6 A.

5. The method according to claim 1 , wherein the RNA molecule lacks (i) a 5′ cap, (ii) an internal ribosome entry site (IRES), or both (i) and (ii).

6. The method according to claim 5 , wherein said introducing is carried out by ligating an RNA molecule comprising a methylated adenosine residue in a 5′ untranslated region (UTR) to the RNA molecule to be translated.

7. The method according to claim 1 , wherein the RNA molecule comprises (i) a 5′ cap, (ii) an internal ribosome entry site (IRES), or both (i) and (ii).

8. The method according to claim 1 , wherein said introducing is carried out by enzymatic methylation.

Assignments (2)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded May 11, 2018
From: JAFFREY, SAMIE R.; MEYER, KATE D.
To: CORNELL UNIVERSITY
Reel/Frame 045776/0430 →
CONFIRMATORY LICENSE Recorded Feb 8, 2018
From: CORNELL UNIVERSITY
To: NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT
Reel/Frame 045267/0418 →
Continuity (2)
Provisional Application 62193464 · Jul 16, 2015
Related Publication 20180195077A1 · Jul 12, 2018